✦ LIBER ✦

In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24

✍ Scribed by Shin-ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Aramaki; Mami Tamai; Satoshi Yamasaki; Hideki Nakamura; Tomoki Origuchi; Yukitaka Ueki; Kiyoshi Migita; Akinari Mizokami; Kiyoshi Aoyagi; Katsumi Eguchi

Publisher: Springer
Year: 2011
Tongue: English
Weight: 163 KB
Volume: 21
Category: Article
ISSN: 1439-7595
DOI: 10.1007/s10165-010-0409-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disease activity score 28 may overestima

Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index

✍ Shin-ya Kawashiri; Atsushi Kawakami; Naoki Iwamoto; Keita Fujikawa; Toshiyuki Ar 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 241 KB

Measures of rheumatoid arthritis disease

Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score Without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA)

✍ Jaclyn K. Anderson; Lani Zimmerman; Liron Caplan; Kaleb Michaud 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 180 KB 👁 2 views

Assessment of the validity of the 28-joi

Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study

✍ Norihiro Nishimoto; Nobuhiro Takagi 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 459 KB

RAPID3 (Routine Assessment of Patient In

RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol

✍ Theodore Pincus; Victoria Furer; Edward Keystone; Yusuf Yazici; Martin J. Bergma 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 150 KB 👁 2 views

Direct comparison of treatment responses

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

✍ Merete Lund Hetland; Ib Jarle Christensen; Ulrik Tarp; Lene Dreyer; Annette Hans 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Low-dose prednisolone in addition to the

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial

✍ Björn Svensson; Annelies Boonen; Kristina Albertsson; Désirée van der Heijde; Ca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of low‐dose prednisolone on joint damage and disease activity in patients with early rheumatoid arthritis (RA). ## Methods At the start of their initial treatment with a disease‐modifying antirheumatic drug (DMARD), patients with early (duration ≤1